previous compound ID: 2518 next compound
InChIKey: WUWDLXZGHZSWQZ-WQLSENKSSA-N
SMILES: CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "J Goepp" "DY Thomas" "J Liao" "JW Hanrahan" "SD Macknight" "E Matthes" "GW Carlile" "R Robert" "D Rotin"

chemical graph of compound 2518





CID is 5329098
synonyms found at PubChem are:
Semaxanib, SU5416, SU 5416, Semaxinib, 204005-46-9, 194413-58-6, Semoxind, Semaxanib (SU5416), SU-5416, Semaxnib, TSU 16, UNII-71IA9S35AJ, VEGF Receptor 2 Kinase Inhibitor III, TSU-16, (Z)-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one, Semaxanib (USAN/INN), (Z)-SU 5416, methylene]-2H-indol-2-one, VEGFR2 Kinase Inhibitor III, 71IA9S35AJ, CHEMBL276711, 3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole, NSC-696819, 3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one, 3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone, 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one, H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, S 8442, (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one, 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl), 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one, InSolution™ VEGF Receptor 2 Kinase Inhibitor III, (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one, (3Z)-3-[(3,5-DIMETHYL-1H-PYRROL-2-YL)METHYLIDENE]-2,3-DIHYDRO-1H-INDOL-2-ONE, Semaxanib(SU5416), SMR000568416, SR-01000076044, Semaxanib [USAN:INN], Sugen 5416, Romiplostim, Z-Semaxanib, NCGC00094381-03, NSC 696819, 2x2m, D01PZD, D04ADG, D0QY0V, SCHEMBL8190, Lopac0_001110, SCHEMBL19571, MLS001074896, MLS001332519, MLS001332520, 3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one, AC1NS627, BDBM4810, GTPL5056, QCR-86, CHEBI:91083, cid_5329098, AOB6828, MolPort-003-959-606, SIBNPBQTUXWRMZ-ZSOIEALJSA-N, WUWDLXZGHZSWQZ-WQLSENKSSA-N, HMS2234L12, HMS3229O13, HMS3263M22, HMS3268J13, HMS3648O12, BCP06068, Tox21 111271, Tox21_501110, 2033AH, 2712AH, BS0306, HSCI1_000303, MFCD01940922, NSC696819, s2845, SU5146, ZINC12410091, AKOS015994557, AN-3643, CCG-205186, CS-1225, DB06436, ES-0010, LP01110, NCGC00094381-01, NCGC00094381-02, NCGC00094381-04, NCGC00094381-05, NCGC00261795-01, AK174866, AK174898, BC600544, DA-43377, HY-10374, LS-83886, QC-11357, SC-96714, AB0094985, LS-193151, RT-016226, EU-0101110, D05819, W-5403, 2H-Indol-2-one,5-dimethyl-2-pyrrolyl)methylene]-, J-013281, SR-01000076044-2, SR-01000076044-8, BRD-K63504947-001-05-5, 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-indolin-2-one, 3-[(3,5-Dimethyl-2H-pyrrol-2-ylidene)methyl]-1H-indol-2-ol, (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one, 3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro- 2H-indol-2-one, 3-[(3,5-dimethyl-1h-pyrrol-2-yl)methylene]-1,3-dihydro-2h-indol-2-one, 2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (3Z)-, 2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (Z)-, 2H-Indol-2-one, 3-(3,5-dimethyl-1H-pyrrol-2-yl)methylene)- 1,3-dihydro-, (Z)-, 3-[1-(3,5-dimethyl-1h-pyrrol-2-yl)-meth-(z)-ylidene]-2-oxo-2,3-dihydro-indole, 267639-76-9